NDC 69097-840 – Ipratropium Bromide and Albuterol Sulfate

Ipratropium Bromide .5 mg/3mL; Albuterol Sulfate 2.5 mg/3mL · Solution · Respiratory (inhalation)

Human Prescription Drug 1 recall

Product NDC69097-840

Product details

Brand name
Ipratropium Bromide and Albuterol Sulfate
Generic name
Ipratropium Bromide and Albuterol Sulfate
Labeler
Cipla USA Inc.
Dosage form
Solution
Route
Respiratory (inhalation)
Marketing category
ANDA · ANDA202496
Marketed since
June 1, 2020
Listing expires
December 31, 2026
Pharmacologic class
Anticholinergic; beta2-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Ipratropium Bromide and Albuterol Sulfate →

Package NDC codes (3)

Package NDCDescriptionSince
69097-840-5330 POUCH in 1 CARTON (69097-840-53) / 1 VIAL in 1 POUCH (69097-840-34) / 3 mL in 1 VIALJun 1, 2020
69097-840-642 POUCH in 1 CARTON (69097-840-64) / 30 VIAL in 1 POUCH / 3 mL in 1 VIALJun 1, 2020
69097-840-871 POUCH in 1 CARTON (69097-840-87) / 30 VIAL in 1 POUCH / 3 mL in 1 VIALJun 1, 2020

Recalls mentioning this NDC

Other Ipratropium Bromide and Albuterol Sulfate products